Error page Patient

For patients prescribed Dupixent in the UK

Error 404

Sorry. We couldn’t find this page for you.

It could be due to any of these reasons:

The URL isn’t spelled correctly
This page has moved
This page no longer exists

Sanofi and Regeneron are collaborating in a global development programme and commercialisation for Dupixent.

Copyright © 2019 Genzyme Therapeutics Limited. All rights reserved.

Terms of Use | Privacy Policy | Cookies Policy | Contact Us

SAGB.DUP.18.05.0740(2) | Date of preparation: July 2019

Leaving to HCP site

This site is intended for U.S. Healthcare Professionals only.

Do you wish to continue?

You are about to leave this website.

This link takes you to a third party website. Sanofi Genzyme has no control over the content of the website you are about to access. The terms of usage of the third party website will differ from that of the www.dupixent.co.uk. It is recommended that you carefully read the legal notice, cookies and privacy policy of third party websites before accessing these sites.

By continuing you are acknowledging that you have read this notice.

You are about to leave sanofi site for U.S.

Sanofi US does not review the information contained on this website and/or database for content, accuracy or completeness. Use of and access to this information is subject to the terms, limitations and conditions set by the website and/or database producer.

This site might not comply with the regulatory requirements of US

You are about to move to an Unbranded site

You are moving to an Unbranded site